This systematic review examined pharmacological and nutraceutical interventions aimed at improving cognitive impairment in bipolar disorder patients. The review synthesized evidence on various treatment approaches, including methylene blue among other compounds, to identify current strategies for addressing cognitive dysfunction in this population. Evidence level: Review of human clinical and related studies.